Clinical Trial Update: The Effect of Nebivolol in Hypertensive Patients With Coronary Artery Disease [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating nebivolol in hypertensive patients with coronary artery disease has completed, with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Hypertension

Drugs mentioned

• BYSTOLIC (nebivolol hydrochloride)

Snippet

Sponsor: Forest Laboratories | Conditions: Hypertension, Coronary Artery Disease | Phase 4 | Status: COMPLETED | Results posted: 2010-09-28